Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB Prevention
Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB Prevention
Recruiting · NCT06281834 · Registry updated 2026-07-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB Prevention | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Infections, bacterial infectious disease, disease arising from reactivation of latent virus, gram-positive bacterial infections, latent tuberculosis infection, mycobacterial infectious disease, tuberculosis | Recruiting | Phase 1 | 2026-07-30 | NCT06281834 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| APIN Public Health Initiatives | 2 |
| Brigham and Women's Hospital | 378 |
| University of Cape Town | 47 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University College Hospital | Ibadan | Nigeria | 1 |